NHS Dudley Health Economy Medicines Formulary
Home > 13 Skin > 13.5 Preparations for eczema and psoriasis > 13.5.3 Drugs affecting the immune response > Psoriatic arthritis (active) - ustekinumab NICE TAG TA313

Psoriatic arthritis (active) - ustekinumab NICE TAG TA313

1.1 Ustekinumab is not recommended within its marketing authorisation for treating active psoriatic arthritis, that is, alone or in combination with methotrexate in adults when the response to previous non-biological disease-modifying antirheumatic drug (DMARD) therapy has been inadequate.

1.2 People currently receiving treatment initiated within the NHS with ustekinumab that is not recommended for them by NICE in this guidance should be able to continue treatment until they and their NHS clinician consider it appropriate to stop.

https://www.nice.org.uk/guidance/TA313

Site by Devopa
© Copyright 2019 NHS. All rights reserved.